Request Deal Involvement

Vivalto Partners, Sagard NewGen, Socadif Capital Investissement, IDIA Capital Investissement and MACSF completed an investment in Delbert Pharma.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

KPMG

financial advisors

KPMG

Edmond de Rothschild Corporate Finance

financial advisors

Edmond de Rothschild Corporate Finance

Bank Neuflize OBC Company Anonyme

debt providers

Bank Neuflize OBC Company Anonyme

Roland Berger

commercial advisors

Roland Berger

LPA Law (LPA-CGR)

legal advisors

LPA Law (LPA-CGR)

Fieldfisher

legal advisors

Fieldfisher

Alvarez & Marsal

tax advisors

Alvarez & Marsal

Cepton Strategies

accounting advisors

Cepton Strategies

Bank Neuflize OBC Company Anonyme

debt providers

Bank Neuflize OBC Company Anonyme

CIC Private Debt

debt providers

CIC Private Debt

Banque Populaire Rives de Paris

debt providers

Banque Populaire Rives de Paris

CMS Legal

legal advisors

CMS Legal

Artemid

debt providers

Artemid

Bpifrance

debt providers

Bpifrance

Société Générale de Surveillance

debt providers

Société Générale de Surveillance

Credit Agricole

debt providers

Credit Agricole

or

Principals

DELBERT PHARMA (EX-LABORATOIRES DELBERT)

target

DELBERT PHARMA (EX-LABORATOIRES DELBERT)

VIVALTO PARTNERS

bidder

VIVALTO PARTNERS

SOCADIF CAPITAL INVESTISSEMENT

bidder

SOCADIF CAPITAL INVESTISSEMENT

SAGARD NEWGEN

bidder

SAGARD NEWGEN

IDIA CAPITAL INVESTISSEMENT

bidder

IDIA CAPITAL INVESTISSEMENT

MACSF

bidder

MACSF

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2026 Datasite

MergerLinks - Request Credit - Vivalto Partners, Sagard NewGen, Socadif Capital Investissement, IDIA Capital Investissement and MACSF completed an investment in Delbert Pharma.